Andrs E et al
1992 Feb 15;282 ( Pt 1)(Pt 1):91-7
In addition, a catalytically active soluble form of DPP4 is also present in plasma
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
Appetite Regulation: By acting on the brains appetite centers, semaglutide can promote a sense of fullness and reduce food intake
Your body needs to adjust to having GLP-1 receptor activation at levels far above what your gut naturally produces